GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSTO:NANOo) » Definitions » Research & Development

Thor Medical ASA (OSTO:NANOO) Research & Development : kr0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Thor Medical ASA's Research & Development for the three months ended in Dec. 2023 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00 Mil.

Thor Medical ASA Research & Development Historical Data

The historical data trend for Thor Medical ASA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA Research & Development Chart

Thor Medical ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 300.62 318.58 317.98 - 0.95

Thor Medical ASA Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Thor Medical ASA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA  (OSTO:NANOo) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Thor Medical ASA Research & Development Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA (OSTO:NANOO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSTO:NANOo) » Definitions » Research & Development
Comparable Companies
OSL:LYTIX OSL:ABS OSL:EXTX OSL:CIRCA OSL:PCIB OSL:ABTEC OSL:SOFTX OSL:CRNA OSL:BGBIO OSL:HBC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
TRMED:Norway 0R6Y:UK 8NN:Germany
Address
Kjelsasveien 168 B, Oslo, NOR, 0884
Website
https://www.nordicnanovector.com
Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (OSTO:NANOO) Headlines

No Headlines